These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3544222)

  • 21. Effect of chronic and progressive increase of portal venous pressure on renal handling of water and electrolytes in rats.
    Blanchart A; Fernández-Muñoz D; Caramelo C; Hernando L; López-Novoa JM
    Miner Electrolyte Metab; 1985; 11(5):295-300. PubMed ID: 3900673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Portal hypertension: experimental and clinical aspects, compensation mechanism of affected splanchnic hemodynamics].
    Liehr H
    Fortschr Med; 1973 Oct; 91(29):1153-8. PubMed ID: 4748916
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat.
    Braillon A; Lee SS; Girod C; Peignoux-Martinot M; Valla D; Lebrec D
    J Lab Clin Med; 1986 Dec; 108(6):543-8. PubMed ID: 3783027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
    Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
    Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
    Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
    Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.
    Wiest R; Jurzik L; Herold T; Straub RH; Schölmerich J
    Peptides; 2007 Feb; 28(2):396-404. PubMed ID: 17194504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
    Zhou YB; Leng X; Qi G
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide and hyperdynamic circulation in portal hypertension.
    Häussinger D
    Hepatology; 1992 Oct; 16(4):1093-4. PubMed ID: 1398491
    [No Abstract]   [Full Text] [Related]  

  • 39. Splanchnic arterial Doppler parameters in portal hypertension.
    Valgimigli M; Piscaglia F; Gaiani S; Bolondi L
    Hepatology; 1999 May; 29(5):1610. PubMed ID: 10336340
    [No Abstract]   [Full Text] [Related]  

  • 40. More on Doppler flowmetry and portal hypertension.
    Burns PN; Blei AT
    Gastroenterology; 1988 Jul; 95(1):260-1. PubMed ID: 2967218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.